Clinical data show remibrutinib treatment leads to significant reductions in urticaria activity scores compared with placebo within the first week.

Artificial intelligence has moved from pilot projects to a central role in many life sciences strategies. What began as a set ...

Careful assessment of symptom patterns allows treatment strategies to be aligned with the patient’s specific challenges ...

February 27, 2026 / Electronic Caregiver, Inc., a nationally deployed AI-driven healthcare infrastructure company headquartered in Las Cruces, announced continued expansion of its operations as part ...

Privacy Examiner is an independent website risk detection and monitoring company focused on identifying externally observable ...

Datalogic highlights RFID-enabled workflows for surgical instruments and implantable device inventory, powered by PowerScan 9600 DPX and RFID, and Memor 17. Teams can accelerate cycle counts, improve ...

How do we take on and resolve vein-related pelvic pain in women? PeVD has been associated with venous-origin chronic pelvic ...

Q4 2025 earnings call: record $589M revenue, 2026 guidance, FIRDAPSE/AGAMREE growth drivers, and key risks—read now.

OpenEvidence has made its AI-integrated Doctor Dialer feature more widely available as it expands its reach into more clinical workflows. | With new features like a clinical AI assistant to transcribe ...

Objective Unplanned hospital readmissions within 30 days of discharge measure the quality of healthcare. This study aims to ...

Treatment episodes were defined by initiation (no visit to the same program in the prior 30 days) and discontinuation (no services for ≥15 days), and retention was calculated as the share of episodes ...

This study estimates the prevalence and workplace productivity burden of obstructive sleep apnoea (OSA) syndrome in the UK and USA, using self-reported breathing pauses and excessive daytime ...